DC Chemicals

DCL0024 · Research use only

A1I4R13C18-2 · Instructions for Use

For trained personnel conducting laboratory research.

ProductInformation
Name / catalogA1I4R13C18-2 / DCL0024
FormulaC67H123N7O4
Molecular weight1090.77
Purity specification>95% by ELSD-HPLC

Before preparation

Confirm batch identity, supply format, storage, solvent compatibility and retest date. Read the supplied batch COA and approved SDS. Use appropriate laboratory protection and avoid repeated transfers of small quantities.

Formulation reference

ComponentDC Chemicals productMolecular weightMolar proportionMass contribution per 1 µmol total lipid
A1I4R13C18-2DCL00241090.7750%0.545385 mg
DSPCDC57005790.1510%0.079015 mg
CholesterolDCD-041386.6538.5%0.148860 mg
DMG-PEGNot uniquely mappedNot specified in the patent1.5%Requires the PEG-lipid molecular weight

Example 6 reports a test-lipid:nucleic-acid mass ratio of 11:1. N/P and PEG-lipid molecular weight are not reported. Refer to the source and the Formulation & Performance page for the evidence and limitations.

Stock-solution calculation

Volume (mL) = mass (mg) × 1000 / [1090.77 × concentration (mM)]. This calculation does not establish solubility.

Mass10 mM volume20 mM volume
10 mg0.9168 mL0.4584 mL
25 mg2.2920 mL1.1460 mL
50 mg4.5839 mL2.2920 mL
100 mg9.1678 mL4.5839 mL
250 mg22.9196 mL11.4598 mL

References

  1. Liu Z, Chen Y, He Z, Yue Z. Cationic lipid analog, and composition and use thereof. WO2023142167A1. Applicant: Guangzhou Lide Biomedicine Technology Co Ltd. Published 3 August 2023. Read the original patent. Compound identities: Example 2 and Table 3; formulation: Example 6 (printed page 19); intravenous mouse study: Example 10 (printed page 20), Table 3 (printed page 27). Printed page numbers refer to the supplied publication; PDF pages are two pages higher.